Company news
Voyageur Pharmaceuticals Ltd (TSXV:VM) news
Voyageur Pharmaceuticals Ltd news releases on 6ix. Latest, Dec 19, 2024: Voyageur Announces Closing of Final Tranche of Private Placement
Press releases — page 2
Voyageur Announces Closing of Final Tranche of Private Placement
December 18, 2024
Voyageur Announces Closing of First Tranche of Private Placement
December 3, 2024
Voyageur Announces Extension to Complete Proposed Private Placement
November 26, 2024
Voyageur Announces Proposed Private Placement
October 17, 2024
Voyageur Pharmaceuticals Grants Stock Options
September 25, 2024
Voyageur Pharmaceuticals Strengthens Leadership Team with Strategic Appointment of Dr. Ibrahim Hashmi as VP of Business Development
September 24, 2024
Voyageur Pharmaceuticals Appoints Dr. Iryna Saranchova as Chief Science Officer, Enhancing the Company's Research and Innovation Leadership
September 17, 2024
Voyageur Introduces Five New Barium Contrast Formulations Setting New Standards in Medical Imaging Industry
September 5, 2024
Voyageur Pharmaceuticals and Rain Cage Carbon Partner to Develop Advanced Radiology Contrast Agents
June 11, 2024
Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development
June 11, 2024
Voyageur Pharmaceuticals Secures $1.9 Million Sales Contract for Latin America
May 28, 2024
Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast
May 28, 2024
Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors
April 3, 2024
Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options
March 26, 2024
Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development
March 13, 2024
Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement
March 4, 2024
Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement
March 1, 2024
Voyageur Pharmaceuticals Ltd. Announces Private Placement
January 16, 2024
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors
December 21, 2023
Voyageur Pharmaceuticals Ltd and Rain Cage Carbon Inc, Announce Breakthrough in Imaging Technology with Vanadium Fullerene Molecule
December 21, 2023
Voyageur Pharmaceuticals takes major step forward announcing international expansion
December 18, 2023
Voyageur Pharmaceuticals Initiates International Expansion
December 14, 2023
Voyageur Pharmaceuticals "sees a gap in the market" for domestically-produced barium
September 28, 2023
Voyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast Media
September 14, 2023
Voyageur Pharmaceuticals Ltd. Announces Filing of Interim Financial Statements, Director Changes and Grant of Stock Options
August 1, 2023
Voyageur Pharmaceuticals Ltd. Announces DSU Grants
July 13, 2023
Voyageur Pharmaceuticals Publishes White Paper, SmoothX: A Promising New Positive Oral Contrast Agent That Enhances Patient Satisfaction and Diagnostic Excellence in CT Imaging
June 12, 2023
Voyageur Pharmaceuticals shares successful environmental assessment for minerals subsidiary
June 8, 2023
Voyageur Pharmaceuticals with a "big market to go for"
June 7, 2023
Voyageur Pharmaceuticals Ltd. Advances with Environmental Field Work at Frances Creek Project Site For Notice of Work & Quarry Permitting
May 31, 2023
The Power Play by The Market Herald Releases New Interviews with Solar Alliance, Cleantek Industries, Voyageur Pharmaceuticals and Homerun Resources Discussing Their Latest News
May 24, 2023
Voyageur Pharmaceuticals partners with Rain Cage to develop nanocarbon-based radiology drugs
May 24, 2023
Voyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast Drugs
May 24, 2023
Voyageur Pharmaceuticals Ltd. Files Interim Financial Statements and Grants Deferred Share Units
April 28, 2023
Voyageur Pharmaceuticals' SmoothX abdominal diagnostic drink gets high praise in comparative study
April 13, 2023
The Power Play by The Market Herald Releases New Interviews with Luminex Resources, Voyageur Pharmaceuticals, Trillion Energy, ARway and Pan Global Resources Discussing Their Latest News
April 11, 2023
Voyageur Pharmaceuticals Ltd. Completes Comparative Studies of its SmoothX(R) Contrast Media Confirming Product Superiority, and announces Option Grant and AGM Date
April 4, 2023
Voyageur Pharmaceuticals Ltd. Files Annual Audited Financial Statements
March 30, 2023
Voyageur Pharmaceuticals Ltd. Provides an Update and Prepares to Launch Initial Sales in Canada
February 14, 2023
Voyageur Pharmaceuticals Ltd. Announces Issuance of Shares for Debt
January 27, 2023
TSX Venture Exchange Stock Maintenance Bulletins
January 24, 2023
Amended: Voyageur Pharmaceuticals Ltd. Announces Final Closing of Increased Private Placement
January 23, 2023
Voyageur Pharmaceuticals Ltd. Announces Final Closing of Increased Private Placement
January 20, 2023
Voyageur Pharmaceuticals Ltd. Announces Increase to Private Placement
January 12, 2023
Voyageur Pharmaceuticals Ltd. Announces First Closing of Private Placement
December 23, 2022
The Power Play by The Market Herald Releases New Interviews with Usha Resources, Voyageur Pharmaceuticals, ARway and Surge Battery Metals Discussing Their Latest News
December 12, 2022
Voyageur Pharmaceuticals Ltd. Announces Canadian Launch of SmoothX (TM) Barium Contrast Media & Financing
December 8, 2022
Voyageur Pharmaceuticals Ltd. Announces Equity Incentive Compensation
December 1, 2022
The Power Play by The Market Herald Releases New Interviews with Trillion, Gamelancer, INEO Tech, ACME Lithium and Voyageur Discussing Their Latest News
November 29, 2022
Voyageur Pharmaceuticals Ltd. Completes Medical Imaging CT Contrast Agent Production Testing and Begins Production Scale-up of SmoothX (TM)
November 28, 2022